Latest Fundraising News

Jumbo Interactive has completed its strategic entry into the US prize draw market by acquiring Dream Giveaway for A$55.4 million, aiming to leverage its digital expertise to fuel growth in a large, underpenetrated market.

Corazon Mining reported a challenging cash flow quarter ending September 2025, with net outflows in operating and investing activities, but secured a $2 million capital raise to support ongoing exploration.

Mindax Limited reported a cash outflow for Q3 2025, with a focus on securing development partners and raising funds to advance its Mt Forrest Iron Project.

Stavely Minerals Limited reported a net cash outflow from operations of AUD 1.264 million for Q3 2025 but bolstered its cash reserves through financing activities, ending the quarter with AUD 1.722 million. The company signals a strategic reduction in exploration expenditure for the upcoming quarter to sustain operations.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Orbminco Limited has completed a promising maiden drilling program at its Majestic North Gold Project, while refreshing its board and consolidating shares to sharpen its strategic focus on Australian gold assets.

Mirvac Group reported a strong start to FY26 with a 79% surge in residential lot sales and a strategic joint venture with Mitsubishi Estate unlocking $450 million in capital. The company reaffirmed its full-year earnings guidance amid robust leasing and development progress.

Navigator Global Investments reports a 3% rise in total assets under management to USD 87 billion, driven by strong growth in Lighthouse Partners and private markets despite a challenging investment landscape.

Tungsten Mining NL (ASX, TGN) reinforces its position as a leading tungsten resource holder outside China, unveiling a robust development strategy aligned with soaring global demand and supply constraints.

AdAlta Limited has raised up to A$0.5 million through a premium-priced private placement, bolstering its 'East to West' cellular immunotherapy strategy focused on advancing CAR-T therapies for solid cancers.

Nimy Resources reminds shareholders of the imminent closing of its Share Purchase Plan, following promising developments at its Mons Critical Mineral project and a recent $1.72 million placement.

Ardiden Ltd’s trading suspension has been lifted following its announcement of a significant gold acquisition and a capital raising initiative, signaling a pivotal moment for the company’s growth strategy.